Rivaroxaban with aspirin

Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Brand:
NICE TA: 607
Indication: Prevention of cardiac events in patients with coronary (CAD) or peripheral artery Disease (PAD) (NICE TA607)
Disease category: Cardiovascular system
Commissioning responsibility: CCG
PbR excluded: No

Background

1.1 Rivaroxaban plus aspirin is recommended within its marketing authorisation, as an option for preventing atherothrombotic events in adults with coronary artery disease or symptomatic peripheral artery disease who are at high risk of ischaemic events.

Recommendation

LMMG recommendation: Green
Click here to find the definitions for the colour classifications

Reason for decision: Suitale for GP prescribing

Supporting documents:

NICE TA607 - Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG	NHS Blackpool CCG	NHS Chorley and South Ribble CCG and NHS Greater Preston CCG	NHS Fylde and Wyre CCG	NHS Morecambe Bay CCG	NHS West Lancashire CCG
			Grey

Medicines